Metraipolis › archive › dc_c2ee056c820f

Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design — Europe PMC PMID:42334917

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42334917
DOI
10.1001/jamanetworkopen.2026.25152
License (as archived)
solo-consultazione
Archived
2026-11-01T00:17:37.205Z
SHA-256 of the archived text
82ab046c92425fc6ad8c84afab6cf52bc072172c3e8c54ed89748ac84fa100a4
Stable URL of this page
https://metraipolis.com/documento/dc_c2ee056c820f

How to cite

Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design — Europe PMC PMID:42334917 — Europe PMC (en), https://europepmc.org/article/MED/42334917 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2ee056c820f (Metraipolis archive dc_c2ee056c820f, sha256 82ab046c92425fc6ad8c84afab6cf52bc072172c3e8c54ed89748ac84fa100a4)
BibTeX
@misc{dcc2ee056c820f,
  title = {Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design — Europe PMC PMID:42334917},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42334917},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2ee056c820f; sha256 82ab046c92425fc6ad8c84afab6cf52bc072172c3e8c54ed89748ac84fa100a4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42334917. Agents can read the archived copy with the MCP tool read_document.